Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sun Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Sun Pharmaceutical Industries Ltd (SUNPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Aug 2016 Thomson Reuters Stock Report 11 $25.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

24 Aug 2016 GlobalData 170 $300.00

MOSL: SUN PHARMA 1QFY17 (Buy)-Strong quarter led by gGleevec-Base business ramp-up is key

SUN PHARMA 1QFY17: Strong quarter led by gGleevec; Base business ramp-up is key (SUNP IN, Mkt Cap USD28.9b, CMP INR802, TP I...

16 Aug 2016 Motilal Oswal Securities Ltd. 12 $115.00

Spark Capital: 1QFY17 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 817)

1QFY17 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 817) How does our one year outlook change? ...

16 Aug 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

Sun Pharmaceutical Industries Ltd_Q1FY17 Result Update

Sun Pharmaceuticals Industries’ (SUNP IN) financial performance was in-line with our expectation, led by Gleevac exclusivity ...

16 Aug 2016 IndiaNivesh Securities Pvt Ltd 6 $58.00

Sun Pharmaceuticals (SUNP) - Qtr. Update - Dated - August 12, 2016

Sun Pharma’s Q1 EBITDA was in line with our estimate led by strong US sales growth of 25% YoY (5% QoQ) driven by steady gGlee...

13 Aug 2016 Axis Capital Limited 8 $81.00

Wright Investors Service Comprehensive Report for Sun Pharmaceuticals Industries Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

12 Aug 2016 Wright Reports 60 $75.00

Taro Pharmaceuticals_Q1FY17 Result Flash Note

At CMP of Rs 794, Sun Pharma is trading at 26.2x FY17E EPS of Rs 30 and 22.3x FY18E EPS of Rs35.6. Currently we have HOLD rat...

11 Aug 2016 IndiaNivesh Securities Pvt Ltd 3 $23.00

MOSL: SUN PHARMA (Buy)-Niche approval likely to boost near-term profits

SUN PHARMA: Niche approval likely to boost near-term profits (SUNP IN, Mkt Cap USD29.9b, CMP INR829, TP INR925, 12% Upside, ...

03 Aug 2016 Motilal Oswal Securities Ltd. 6 $46.00